Biogen Inc. has notified the European Medicines Agency (EMA) of its decision to withdraw its Marketing Authorization Application (MAA) for aducanumab for the treatment...
Nkarta, Inc., a biopharmaceutical company developing engineered natural killer cell therapies to treat cancer, announced positive preliminary Phase 1 data from independent dose finding...
A new case of Ebola has been confirmed in northwestern Democratic Republic of Congo, prompting health authorities to enforce urgent containment measures just four...
New research has shown that a longer interval between primary COVID-19vaccine doses can boost antibody production up to nine-fold. The study currently being presented at...
Roche announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Tecentriq® (atezolizumab) as...
Health authorities around the world are investigating a mysterious increase in severe cases of hepatitis in young children. More than 130 cases have been...